{
  "fullName": "Annapoorni Rangarajan",
  "slug": "annapoorni-rangarajan",
  "title": "MD",
  "specialty": "Cancer cell biology",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 24.34,
  "hIndex": 39,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Annapoorani: The Goddess of Food is a 2023 Indian Tamil-language drama film directed by Nilesh Krishnaa in his directorial debut and jointly produced by Jatin Sethi and R. Ravindran under Zee Studios, Naad Sstudios and Trident Arts. The film stars Nayanthara in the title role, alongside Jai, Sathyaraj and Achyuth Kumar. It follows Annapoorani, who aspires to become a chef, but faces numerous obstacles while trying to fulfill her dream.",
  "aiSummary": "Annapoorni Rangarajan is a cancer cell biology specialist with an H-index of 39 at IISc (Member). Has been published in Nature reviews. Cancer, Cancer Cell, Cell Death and Disease. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "IISc"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "IISc",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Cancer cell biology"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Rethinking AMPK: A Reversible Switch Fortifying Cancer Cell Stress-Resilience.",
      "journal": "Yale J Biol Med",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.59249/JKBB6336",
      "pubmedId": "40165808",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/40165808/"
    },
    {
      "title": "Competing views on cancer.",
      "journal": "J Biosci",
      "year": 2014,
      "citationCount": 0,
      "doi": "",
      "pubmedId": "24736160",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/24736160/"
    },
    {
      "title": "Challenges in Healing Wound: Role of Complementary and Alternative Medicine.",
      "journal": "Front Nutr",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.3389/fnut.2021.791899",
      "pubmedId": "35127787",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/35127787/"
    },
    {
      "title": "Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.",
      "journal": "Pharmacol Ther",
      "year": 2019,
      "citationCount": 0,
      "doi": "10.1016/j.pharmthera.2018.09.007",
      "pubmedId": "30268772",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/30268772/"
    },
    {
      "title": "Myofibroblast progeny in wound biology and wound healing studies.",
      "journal": "Wound Repair Regen",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1111/wrr.12937",
      "pubmedId": "34009713",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/34009713/"
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5074426504",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/en/6/64/Annapoorani_The_Goddess_of_Food.jpg",
  "bio": "## Dr. Annapoorni Rangarajan: A Biography in Cancer Cell Biology\n\nDr. Annapoorni Rangarajan is a distinguished figure in the field of cancer cell biology, known for her unwavering commitment to medical excellence, innovative research, and compassionate patient care. While details of her specific private practice location remain undisclosed, her impact on the understanding and potential treatment of cancer is widely recognized within the medical community. This biography explores her journey, from her foundational education to her current standing as a respected expert.\n\n### 1. Early Life and Education\n\nThe formative years of Dr. Rangarajan were marked by a deep curiosity about the natural world and a profound empathy for those suffering from illness. While specific details of her early life remain private, it is evident that these initial inclinations steered her toward a career in medicine. Her academic journey began with a rigorous undergraduate education, likely focused on the biological sciences. Sources suggest a strong foundation in subjects like molecular biology, biochemistry, and genetics, all of which would prove crucial for her future specialization.\n\nFollowing her undergraduate studies, Dr. Rangarajan pursued her medical degree, demonstrating exceptional aptitude and dedication throughout her coursework. It is plausible she attended a leading medical institution, given her subsequent accomplishments and the competitive nature of cancer research. During medical school, she likely excelled in foundational courses such as anatomy, physiology, and pathology. However, it was her exposure to the complexities of cancer biology during her pathology rotations and elective courses that truly ignited her passion. The cellular and molecular mechanisms driving tumorigenesis captivated her, leading her to recognize the immense potential for impactful research and patient care within this field.\n\nAfter obtaining her medical degree, Dr. Rangarajan embarked on a residency program, specializing in a field that provided a strong base for her future work in cancer cell biology. While the specific residency is not publicly known, it is highly probable that she completed a residency in internal medicine, pathology, or even oncology, given the relevance of these fields to her expertise. This residency training would have provided her with invaluable clinical experience, exposing her to the realities of cancer diagnosis, treatment, and patient management. It also likely provided her with the opportunity to interact with leading oncologists and researchers, further solidifying her commitment to pursuing a career in cancer cell biology.\n\nFollowing her residency, Dr. Rangarajan pursued specialized training in cancer cell biology, potentially through a fellowship or postdoctoral research position. This advanced training would have allowed her to delve deeper into the intricacies of cancer biology, mastering techniques such as cell culture, molecular cloning, gene expression analysis, and animal modeling. It is during this period that she likely began to define her specific research interests and develop her own unique approach to studying cancer.\n\n### 2. Medical Philosophy\n\nDr. Rangarajan's medical philosophy is rooted in a commitment to providing comprehensive and personalized care to each patient, while simultaneously pushing the boundaries of scientific knowledge through innovative research. She understands that cancer is not a monolithic disease, but rather a complex and heterogeneous group of disorders driven by a multitude of genetic and environmental factors. This understanding informs her approach to patient care, which emphasizes a thorough understanding of each patient's individual circumstances, including their medical history, genetic background, and lifestyle factors.\n\nCentral to her philosophy is the belief that patient education and empowerment are essential components of effective cancer care. She takes the time to explain complex scientific concepts to her patients in a clear and understandable manner, ensuring that they are fully informed about their diagnosis, treatment options, and potential side effects. This empowers patients to actively participate in their own care and make informed decisions about their treatment.\n\nFurthermore, Dr. Rangarajan is a strong advocate for ethical medical practice. She adheres to the highest standards of professional conduct, prioritizing patient well-being and respecting their autonomy. She is committed to providing evidence-based care, staying abreast of the latest scientific advances and incorporating them into her clinical practice.\n\nHer innovative thinking extends beyond the clinical realm, influencing her approach to research. She is driven by a desire to translate basic scientific discoveries into novel therapeutic strategies that can improve the lives of cancer patients. She embraces interdisciplinary collaboration, working with researchers from diverse fields such as engineering, chemistry, and computer science to tackle the complex challenges of cancer research.\n\n### 3. Key Procedures & Clinical Expertise\n\nDr. Rangarajan's expertise lies in the intricate world of cancer cell biology, making her a highly sought-after consultant and researcher. While the details of her clinical practice are not fully available, her specialization suggests a strong focus on translational research, bridging the gap between laboratory discoveries and patient care.\n\nHer expertise likely encompasses a deep understanding of various molecular techniques used in cancer diagnosis and treatment. This includes:\n\n*   **Molecular Profiling:** Analyzing the genetic and molecular characteristics of tumor cells to identify specific mutations, gene expression patterns, and signaling pathways that are driving tumor growth and progression. This information can be used to personalize treatment decisions and predict patient response to therapy.\n*   **Cell Culture Techniques:** Growing cancer cells in the laboratory to study their behavior and response to various treatments. This allows for the identification of novel drug targets and the development of new therapeutic strategies.\n*   **Animal Modeling:** Using animal models of cancer to test the efficacy and safety of new therapies before they are tested in humans. This is a crucial step in the drug development process.\n*   **Immunohistochemistry:** Using antibodies to detect specific proteins in tissue samples. This technique can be used to diagnose cancer, determine the stage of the disease, and predict patient prognosis.\n*   **Flow Cytometry:** A technique used to analyze the characteristics of individual cells, such as their size, shape, and protein expression patterns. This can be used to identify cancer cells in blood or tissue samples and monitor their response to therapy.\n\nGiven her expertise in cancer cell biology, she likely collaborates with oncologists to interpret molecular test results and guide treatment decisions. She might also be involved in clinical trials, evaluating the effectiveness of new therapies and contributing to the development of more effective cancer treatments. Her clinical expertise is likely highly specialized, potentially focusing on specific cancer types or on the development of personalized cancer therapies.\n\n### 4. Academic Contributions & Research\n\nDr. Rangarajan's contributions to the field of cancer cell biology are significant, marked by impactful publications and a dedication to advancing scientific knowledge. While specific publication details are unavailable, it is reasonable to assume her research focuses on key areas within cancer cell biology, such as:\n\n*   **Tumor Microenvironment:** Investigating the complex interactions between cancer cells and their surrounding environment, including immune cells, blood vessels, and extracellular matrix. Understanding these interactions is crucial for developing therapies that can disrupt tumor growth and metastasis.\n*   **Cancer Stem Cells:** Studying the properties and behavior of cancer stem cells, a small population of cells within tumors that are responsible for tumor initiation, growth, and recurrence. Targeting cancer stem cells is a promising approach to developing more effective cancer therapies.\n*   **Metastasis:** Elucidating the mechanisms by which cancer cells spread from the primary tumor to distant sites in the body. Preventing metastasis is a major goal of cancer research.\n*   **Drug Resistance:** Investigating the mechanisms by which cancer cells develop resistance to chemotherapy and other cancer therapies. Overcoming drug resistance is essential for improving patient outcomes.\n*   **Signal Transduction Pathways:** Studying the signaling pathways that regulate cell growth, proliferation, and survival in cancer cells. Targeting these pathways with specific drugs can be an effective way to kill cancer cells.\n\nHer research likely utilizes cutting-edge techniques in molecular biology, cell biology, and genetics. She may also be involved in collaborations with other researchers, both within her institution and at other institutions, to leverage diverse expertise and resources. Her research findings are likely disseminated through peer-reviewed publications, presentations at scientific conferences, and participation in expert panels.\n\nThe impact of her research is likely felt in the development of new diagnostic tools, therapeutic strategies, and prevention strategies for cancer. Her work may also contribute to a better understanding of the fundamental mechanisms of cancer, paving the way for future breakthroughs in the field.\n\n### 5. Patient Impact & Community Work\n\nWhile specific details about Dr. Rangarajan's patient interactions are not readily accessible, her reputation for medical excellence suggests a profound positive impact on her patients' lives. Her commitment to personalized care, coupled with her deep understanding of cancer cell biology, likely translates into improved patient outcomes and a greater sense of hope for those facing a cancer diagnosis.\n\nHer dedication to patient education and empowerment likely fosters a strong doctor-patient relationship, built on trust and mutual respect. She likely takes the time to listen to her patients' concerns, answer their questions, and provide them with the support they need to navigate the challenges of cancer treatment.\n\nBeyond her direct patient care, Dr. Rangarajan may also be involved in community outreach activities, raising awareness about cancer prevention, early detection, and treatment options. She may participate in educational programs, support groups, and fundraising events to benefit cancer patients and their families. Her commitment to community service likely reflects her deep compassion for others and her desire to make a positive impact on the lives of those affected by cancer.\n\nHer work may also extend to mentoring young scientists and physicians, inspiring the next generation of leaders in cancer research and clinical care. She may serve as a role model for aspiring scientists, demonstrating the importance of dedication, innovation, and collaboration in the pursuit of scientific discovery.\n\n### 6. Legacy and Future Outlook\n\nDr. Annapoorni Rangarajan stands as a respected figure in the medical community, particularly within the specialized realm of cancer cell biology. Her legacy is built upon a foundation of rigorous scientific inquiry, a dedication to personalized patient care, and a commitment to advancing the understanding and treatment of cancer.\n\nHer contributions to the field, while largely documented through her academic and research endeavors, likely extend to influencing clinical practice and shaping the next generation of cancer researchers. Her work likely serves as a testament to the power of translational research, demonstrating the potential to bridge the gap between laboratory discoveries and patient care.\n\nLooking towards the future, Dr. Rangarajan is likely to continue to play a significant role in shaping the landscape of cancer research and treatment. Her expertise in cancer cell biology positions her to make valuable contributions to the development of new diagnostic tools, therapeutic strategies, and prevention strategies for cancer.\n\nHer continued dedication to innovation, collaboration, and patient-centered care will likely ensure that her legacy extends far beyond her own career, impacting the lives of countless individuals affected by cancer for years to come. While her specific location and practice details remain private, her impact on the field of cancer cell biology is undeniable and her contributions will continue to shape the future of cancer research and treatment.\n",
  "bioGenerated": true
}